This Project Grant award of $81,377,097, provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, supports the Washington State Opioid Response Grant - SOR IV. The project is designed to address the opioid epidemic in Washington state by implementing the state's 2021-2022 Opioid and Overdose Response Plan. Key products and services delivered through...
The South Carolina State Opioid Response Project (SC SOR Project), a $75,192,656 Project Grant awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, aims to address the opioid and stimulant use disorder crisis in South Carolina through comprehensive prevention, treatment, harm reduction, and recovery support services. The initiative leverages...
The Oregon Health Authority (OHA) received a $45,830,769 Project Grant award under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program from the Substance Abuse and Mental Health Services Administration (SAMHSA). The award, titled "SOR 4 - The Oregon State Opioid Response (SOR) 4 Grant", will focus on regions and populations in Oregon with high rates of opioid and stimulant use disorders, high overdose rates, and low...
This federal Project Grant award of $159,454,968 was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The goal of the Maryland State Opioid Response IV (SOR IV) Initiative is to increase access to and enhance the reach and capacity of prevention, treatment, and recovery support services for individuals with opioid and/or stimulant use...
This Project Grant award was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant, totaling $400,907,000, will fund the Ohio's State Opioid and Stimulant Response (SOS) 4.0 program. Key services to be delivered include: Expanding access to harm reduction, peer recovery supports, and evidence-based substance use disorder treatment, with...
This federal Block Grant award of $43,892,064 was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Block Grants for Prevention and Treatment of Substance Abuse program (CFDA 93.959). The funding supports a range of substance abuse prevention, treatment, and recovery services across the state of Georgia. Key products and services delivered through this award include: Forensic peer mentor training and workforce expansion to reduce recidivism among...
The Missouri Department of Mental Health, through its Division of Behavioral Health, has been awarded a $79,042,881 State Opioid Response (SOR) Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under CFDA Program 93.788. This 3-year project grant, effective from September 30, 2024 to September 29, 2027, will support a comprehensive set of activities to address the opioid crisis in Missouri. Key program components include improving the state's prescription drug...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $375,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to Southern Healthcare Collaboration, Inc. The grant will fund the "Mind, Body & Soul" initiative, which will provide comprehensive services to address substance abuse, mental health challenges, and improve healthcare access in the rural counties of Appling,...
This federal Project Grant award of $2,250,000 was provided by the U.S. Department of Health and Human Services Health Resources and Services Administration (HRSA) under the Rural Health Research Centers (CFDA 93.155) program. The grant will support Southern Healthcare Collaboration, Inc., a non-profit organization, in implementing a comprehensive initiative to expand access to substance use disorder treatment and recovery services in the rural Georgia counties of Appling and Bacon. The...
The U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $75,500,157 Project Grant on Sep 30, 2024 under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the Government of the District of Columbia. This funding will support the DCOR 4 initiative, which aims to address the opioid overdose crisis in Washington, D.C. by increasing access to medication for opioid...
This $86,879,418 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program will fund the Georgia State Opioid Response (SOR) IV Project. The project aims to expand and sustain treatment and recovery support services, naloxone distribution, prevention education, and training for providers in high-need areas of Georgia to address the opioid crisis. An estimated 4,800 individuals with opioid use disorder will be served, and an additional 1,000,000 individuals will be reached through prevention services and media campaigns over the 3-year project period. The award will also fund sub-grants to organizations providing peer recovery coaching, naloxone administration, prevention education, and training for first responders and healthcare professionals across the state.